Masoudi M, Sharifi Z, Maghsudlu M. Molecular detection of HTLV-1 provirus from DNA released from cells in plasma, in cases of lack of access to genomic DNA of peripheral blood mononuclear cells. Sci J Iran Blood Transfus Organ 2024; 21 (2) :138-150 URL: http://bloodjournal.ir/article-1-1529-en.html
Iwamoto N, Araki T, Umetsu A, Takatani A, Aramaki T, Ichinose K, et al. The Association of Increase of Human T-Cell Leukemia Virus Type-1 (HTLV-1) Proviral Load (PVL) With Infection in HTLV-1-Positive Patients With Rheumatoid Arthritis: A Longitudinal Analysis of Changes in HTLV-1 PVLs in a Single Center Cohort Study. Front Immunol 2022; 13: 887783.
de La-Roque DGL, Santos EV, Rodrigues ES, da Costa PNM, Brauer VS, Almeida F, et al. The Expression of Tax and HBZ Genes in Serum-Derived Extracellular Vesicles From HTLV-1 Carriers Correlates to Proviral Load and Inflammatory Markers. Front Immunol 2022; 13: 881634.
Simioli FR, Bouzas MB, Mijalovsky D, Pineda MV, Mammana L, Mangano A, Orduna TA. Making Visible HTLV Infection in a Non-endemic Area of Argentina. Front Med (Lausanne) 2022; 9: 892159.
Mozhgani SH, Kermani HA, Norouzi M, Arabi M, Soltani S. Nanotechnology based strategies for HIV-1 and HTLV-1 retroviruses gene detection. Heliyon 2020; 6(5): e04048.
Komatsu N, Iwanaga M, Hasegawa Y, Miura S, Fuchi N, Moriuchi H, et al. Frequency of HTLV-1 seroconversion between pregnancies in Nagasaki, Japan, 2011-2018. Front Microbiol 2022; 13: 1036955.
Haghnazari Sadaghiani N, Pirayeshfard L, Aghaie A, Sharifi Z. The Effect of TAX-1 Gene of Human T-cell Leukemia Virus Type-1 on the Expression of CCR5 in K562 Cell Line. Avicenna J Med Biotechnol 2019; 11(1): 67-71.
Futsch N, Mahieux R, Dutartre H. HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment. Viruses 2017; 10(1): 1.
Saffari M, Rahimzada M, Mirhosseini A, Ghezaldasht SA, Valizadeh N, Moshfegh M, et al. Coevolution of HTLV-1-HBZ, Tax, and proviral load with host IRF-1 and CCNA-2 in HAM/TSP patients. Infect Genet Evol 2022; 103: 105337.
Ji H, Chang L, Yan Y, Wang L. Development and validation of a duplex real-time PCR for the rapid detection and quantitation of HTLV-1. Virol J 2023; 20(1): 9.
Eusebio-Ponce E, Candel FJ, Paulino-Ramirez R, Serrano-García I, Anguita E. Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017. Rev Esp Quimioter 2021; 34(1): 44-50.
Forlani G, Shallak M, Accolla RS, Romanelli MG. HTLV-1 infection and pathogenesis: New insights from cellular and animal models. Int J Mol Sci 2021; 22(15): 8001.
Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, et al. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003; 299(5613): 1713-6.
Kalinichenko S, Komkov D, Mazurov D. HIV-1 and HTLV-1 transmission modes: Mechanisms and importance for virus spread. Viruses 2022; 14(1): 152.
Song HS, Kang DH, Kim H, Ahn TS, Kim TW, Baek MJ. Clinical relevance and prognostic role of preoperative cell-free single-stranded DNA concentrations in colorectal cancer patients. Korean J Clin Oncol 2021; 17(2): 59.
Mayo S, Gómez-Manjón I, Fernández-Martínez FJ, Camacho A, Martínez F, Benito-León J. CfDNA measurement as a diagnostic tool for the detection of brain somatic mutations in refractory epilepsy. Int J Mol Sci 2022; 23(9): 4879.
Melamud MM, Buneva VN, Ermakov EA. Circulating Cell-Free DNA Levels in Psychiatric Diseases: A Systematic Review and Meta-Analysis. Int J Mol Sci 2023; 24(4): 3402.
Pös Z, Pös O, Styk J, Mocova A, Strieskova L, Budis J, et al. Technical and methodological aspects of cell-free nucleic acids analyzes. Int J Mol Sci 2020; 21(22): 8634.
Pirayeshfard L, Sharifi Z, Amini-Kafiabad S, Haghnazari Sadaghiani N. Phylogenetic analysis of HTLV-1 in Iranian blood donors, HIV-1 positive patients and patients with beta thalassemia. J Med Virol 2018; 90(8): 1398-1405.
Ghasemzadegan H, Shahabi M, Rezaei N, Sharifi Z. Design a Real Time PCR with SYBR Green for quantification of HTLV-1 proviral load for blood donors. Sci J Iran Blood Transfus Organ 2019; 16(3): 194-200. [Article in Farsi]
Miley WJ, Suryanarayana K, Manns A, Kubota R, Jacobson S, Lifson JD, Waters D. Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. AIDS Res Hum Retroviruses 2000; 16(7): 665-75.
Rosadas C, Cabral-Castro MJ, Vicente ACP, Peralta JM, Puccioni-Sohler M. Validation of a quantitative real-time PCR assay for HTLV-1 proviral load in peripheral blood mononuclear cells. J Virol Methods 2013; 193(2): 536-41.
Kustanovich A, Schwartz R, Peretz T, Grinshpun A. Life and death of circulating cell-free DNA. Cancer Biol Ther 2019; 20(8): 1057-67.
Bronkhorst AJ, Ungerer V, Holdenrieder S. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol Detect Quantif 2019; 17: 100087.
Joris T, Haddow J, Taylor GP, Cook LB, Rowan AG. Detection of HTLV-1 proviral DNA in cell-free DNA: Potential for non-invasive monitoring of Adult T cell leukaemia/lymphoma using liquid biopsy? Front Immunol 2023; 14: 1150285.
Katsuya H, Nakamura H, Maeda A, Ishii K, Nagaie T, Sano H, et al. HTLV‐1 cell‐free DNA in plasma as a potential biomarker in HTLV‐1 carriers and adult T‐cell leukemia‐lymphoma. EJHaem 2023; 4(3): 733-7.
Rosa DV, Magno LA, Pereira NC, Romanelli LC, Albuquerque MR, Martins ML, et al. Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals. Biomark Med 2018;
12(5): 447-54.
Furtado MdSBS, Andrade RG, Romanelli LCF, Ribeiro MA, Ribas JG, Torres EB, et al. Monitoring the HTLV‐1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV‐associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease. J Med Virol 2012; 84(4): 664-71.
Cabral F, Arruda LB, de Araújo ML, Montanheiro P, Smid J, de Oliveira ACP, et al. Detection of human T-cell lymphotropic virus type 1 in plasma samples. Virus Res 2012; 163(1): 87-90.
Fan N, Gavalchin J, Paul B, Wells K, Lane M, Poiesz B. Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I. J Clin Microbiol 1992; 30(4): 905-10.
Derse D, Hill SA, Lloyd PA, Chung H-k, Morse BA. Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J Virol 2001; 75(18): 8461-8.
Al Sharif S, Pinto DO, Mensah GA, Dehbandi F, Khatkar P, Kim Y, et al. Extracellular vesicles in HTLV-1 communication: the story of an invisible messenger. Viruses 2020; 12(12): 1422.
Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic 2010; 11(5): 675-87.
Pinto DO, DeMarino C, Pleet ML, Cowen M, Branscome H, Al Sharif S, et al. HTLV-1 extracellular vesicles promote cell-to-cell contact. Front Microbiol 2019; 10: 2147.
Pinto DO, Al Sharif S, Mensah G, Cowen M, Khatkar P, Erickson J, et al. Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread. Retrovirology 2021; 18(1): 1-27.
Sci J Iran Blood Transfus Organ 2024; 21 (2): 138-150
Original Article
Molecular detection of HTLV-1 provirus from DNA released from cells in plasma, in cases of lack of access to genomic DNA of peripheral blood mononuclear cells Masoudi M.1, Sharifi Z.1, Maghsudlu M.1 1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran Abstract Background and Objectives Human lymphotropic virus type I mainly infects lymphocytes. For the detection of this virus, mainly nucleated cells are evaluated. Due to the short longevity of cells, sample collection is a challenge. The purpose of the study was to investigate the presence of HTLV-1 virus in genomic DNA released from cells in plasma and to determine its viral load in Western blot-positive blood donors.
Materials and Methods In this descriptive study, 30 HTLV-1 positive Western blot donors were evaluated. Using an extraction kit, genomic DNA was extracted from plasma and isolated PBMC using Ficol. A nested PCR test was used to confirm the presence of HTLV-1 virus. A real-time PCR quantitative test by Sybergreen method was used to determine the amount of virus load.
Results The average age of subjects was 42.9 ± 13.5 years; 93.3% of them were male and 6.6% female. LTR gene region was detected by nested PCR method in 80% of plasma and 100% of PBMC samples. The median viral loads in plasma and PBMC were 1.90 Copies/µL and 20 copies/106 PBMC, respectively.
Conclusions To detect the HTLV-1 virus by molecular method, the HTLV-1 provirus DNA released from cells, in the plasma can be used when peripheral blood mononuclear cells are unavailable. It has also been observed that the virus load in the plasma of asymptomatic carriers is approximately 10 times lower than in PBMC.
Key words: HTLV-1, Cell-Free Nucleic Acids, qPCR
Received: 2 Mar 2024 Accepted: 13 May 2024
Correspondence: Sharifi Z., PhDof Virology. Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine. P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 82052152; Fax: (+9821) 88601555 E-mail: sharifiz@yahoo.com
Type of Study: Research |
Subject:
Virology Published: 2024/06/30